• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 1.09% Nasdaq Up 0.98%

    Cytokinetics, Incorporated (CYTK)

    -NasdaqCM
    7.40 Up 0.21(2.92%) Jul 28, 4:00PM EDT
    Add to Portfolio
    Prev Close:7.19
    Open:7.25
    Bid:7.40 x 500
    Ask:N/A
    1y Target Est:13.83
    Beta:1.89
    Next Earnings Date:29-Jul-15CYTK Earnings announcement
    Day's Range:7.12 - 7.49
    52wk Range:3.05 - 8.61
    Volume:417,248
    Avg Vol (3m):324,741
    Market Cap:286.51M
    P/E (ttm):N/A
    EPS (ttm):-0.40
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CYTK

    Comparison

    Symbol% ChgMkt Cap
    CYTKUp 2.92%286.51M
    BIIBUp 3.39%75.24B
    LGNDUp 3.21%2.08B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):6.42
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.10
    Quarterly EPS Est (Jun-15) :-0.24
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):-0.43

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Cytokinetics, Incorporated, a clinical stage biopharmaceutical company, focuses on the discovery and development of novel small molecule therapeutics that modulate muscle function for the treatment of serious diseases and medical conditions. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback